Dr Sandra Anne Kopp, MD | |
3 Cooper Plz, Suite 215, Camden, NJ 08103-1438 | |
(856) 342-2014 | |
Not Available |
Full Name | Dr Sandra Anne Kopp |
---|---|
Gender | Female |
Speciality | Dermatology |
Experience | 16 Years |
Location | 3 Cooper Plz, Camden, New Jersey |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1447552948 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 25MA08868200 (New Jersey) | Primary |
207NS0135X | Dermatology - Procedural Dermatology | 25MA08868200 (New Jersey) | Secondary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Nova Dermatology Llc | 9032547047 | 3 |
News Archive
Insomnia is a "prevalent and persistent" problem for patients in the early phases of recovery from the disease of addiction—and may lead to an increased risk of relapse, according to a report in the November/December Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.
Women with a severe mental health-related disability are nearly four times more likely to have been a victim of intimate partner violence than those without a disability, according to a new study by Women's College Hospital researcher Janice Du Mont and co-author Tonia Forte.
Phosphate Therapeutics Limited, a development-stage specialty pharmaceuticals company, today announces positive results from the PEACH pivotal study of PT20 in subjects with hyperphosphataemia related to dialysis dependent chronic kidney disease (DD-CKD).
...according UC Irvine researchers involved with the 90+ Study, one of the nation's largest studies of dementia and other health factors in the fastest-growing age demographic.
› Verified 4 days ago
Entity Name | Nova Dermatology Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538626049 PECOS PAC ID: 9032547047 Enrollment ID: O20200325000012 |
News Archive
Insomnia is a "prevalent and persistent" problem for patients in the early phases of recovery from the disease of addiction—and may lead to an increased risk of relapse, according to a report in the November/December Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.
Women with a severe mental health-related disability are nearly four times more likely to have been a victim of intimate partner violence than those without a disability, according to a new study by Women's College Hospital researcher Janice Du Mont and co-author Tonia Forte.
Phosphate Therapeutics Limited, a development-stage specialty pharmaceuticals company, today announces positive results from the PEACH pivotal study of PT20 in subjects with hyperphosphataemia related to dialysis dependent chronic kidney disease (DD-CKD).
...according UC Irvine researchers involved with the 90+ Study, one of the nation's largest studies of dementia and other health factors in the fastest-growing age demographic.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Sandra Anne Kopp, MD 3 Cooper Plz, Suite 215, Camden, NJ 08103-1438 Ph: () - | Dr Sandra Anne Kopp, MD 3 Cooper Plz, Suite 215, Camden, NJ 08103-1438 Ph: (856) 342-2014 |
News Archive
Insomnia is a "prevalent and persistent" problem for patients in the early phases of recovery from the disease of addiction—and may lead to an increased risk of relapse, according to a report in the November/December Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.
Women with a severe mental health-related disability are nearly four times more likely to have been a victim of intimate partner violence than those without a disability, according to a new study by Women's College Hospital researcher Janice Du Mont and co-author Tonia Forte.
Phosphate Therapeutics Limited, a development-stage specialty pharmaceuticals company, today announces positive results from the PEACH pivotal study of PT20 in subjects with hyperphosphataemia related to dialysis dependent chronic kidney disease (DD-CKD).
...according UC Irvine researchers involved with the 90+ Study, one of the nation's largest studies of dementia and other health factors in the fastest-growing age demographic.
› Verified 4 days ago